Literature DB >> 10204618

Influence of histological inflammatory activity on regenerative capacity of liver after percutaneous transhepatic portal vein embolization.

H Tanaka1, K Hirohashi, S Kubo, T Ikebe, T Tsukamoto, H Hamba, T Shuto, K Wakasa, H Kinoshita.   

Abstract

Percutaneous transhepatic portal vein embolization (PTPE) produces regenerative hypertrophy in the nonembolized part of the liver, but the regenerative capacity after PTPE in patients with chronic hepatitis is unknown. We studied 34 patients with hepatocellular carcinoma and chronic hepatitis who underwent PTPE at the right portal vein. Hepatic lobular volumes were calculated by computed tomography before and 2 weeks after PTPE. The increase in left lobular volume was analyzed using a stepwise multiple regression method incorporating 11 factors: age; portal venous pressure; proportional volume of the right lobe; indocyanine green retention test; platelet count; serum levels of aspartate transaminase, alanine transaminase, total bilirubin, and albumin; and histological inflammatory grade and stage of fibrosis, according to the criteria of the International Association for the Study of the Liver recommended at their 1994 meeting. The median volume of the left lobe had increased from 405 to 554 cm3 (P < 0.0001) by 2 weeks after PTPE. Inflammatory grade was the only independent factor predicting regenerative hypertrophy (regeneration ratio (%) = 80.3 - 20.1 x grade; standard correlation coefficient = -0.566; P = 0.0014). Histological inflammatory activity was the essential factor regulating liver regeneration after PTPE in patients with chronic hepatitis.

Entities:  

Mesh:

Year:  1999        PMID: 10204618     DOI: 10.1007/s005350050223

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  6 in total

Review 1.  Portal vein embolization before major hepatectomy.

Authors:  Hai Liu; Yong Fu
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

2.  Role of preoperative selective portal vein embolization in two-step curative hepatectomy for hepatocellular carcinoma.

Authors:  Wu Ji; Jie-Shou Li; Ling-Tang Li; Wu-Hong Liu; Kuan-Sheng Ma; Xiang-Tian Wang; Zhen-Ping He; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

3.  Correlation between preoperative serum concentration of type IV collagen 7s domain and hepatic failure following resection of hepatocellular carcinoma.

Authors:  Shoji Kubo; Tadashi Tsukamoto; Kazuhiro Hirohashi; Hiromu Tanaka; Taichi Shuto; Shigekazu Takemura; Takatsugu Yamamoto; Takahiro Uenishi; Masao Ogawa; Hiroaki Kinoshita
Journal:  Ann Surg       Date:  2004-02       Impact factor: 12.969

4.  Portal vein embolization before right hepatectomy: prospective clinical trial.

Authors:  Olivier Farges; Jacques Belghiti; Reza Kianmanesh; Jean Marc Regimbeau; Roberto Santoro; Valérie Vilgrain; Alban Denys; Alain Sauvanet
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

5.  HA/GSA-Rmax ratio as a predictor of postoperative liver failure.

Authors:  Masaki Kaibori; Sang Kil Ha-Kawa; Morihiko Ishizaki; Kosuke Matsui; Takamichi Saito; A-Hon Kwon; Yasuo Kamiyama
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

Review 6.  Portal Vein Embolization: History and Current Indications.

Authors:  Hiroji Shinkawa; Shigekazu Takemura; Shogo Tanaka; Shoji Kubo
Journal:  Visc Med       Date:  2017-11-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.